Heme oxigenase 2 gene polymorphisms as genetic risk factor in atherosclerosis in Iranian patients

Iranian Red Crescent Medical Journal

Volumn 12, Issue 5, 2010, Pages 559-563

  Zamani, M ^a   Aleyasin, A ^a   Fakhrzadeh, H ^b   Kiavar, M ^c   Raoufzadeh, S ^a   Larijani, B ^b   Mahmoodi, E ^b  

^a NATIONAL INSTITUTE OF GENETIC ENGINEERING AND BIOTECHNOLOGY   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Atherosclerosis; Coronary artery disease; Heme oxigenase 2; Iran

Indexed keywords

HEME OXYGENASE 2; POLYACRYLAMIDE GEL; PRIMER DNA;

ADULT; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CODON; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA POLYMORPHISM; EXON; FEMALE; GENE AMPLIFICATION; GENE MUTATION; GENE SEQUENCE; GENETIC RISK; HUMAN; IRAN; MAJOR CLINICAL STUDY; MALE; POPULATION; SINGLE STRAND CONFORMATION POLYMORPHISM;

EID: 77957336380     PISSN: 20741804     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Gaziano JM. When should heart disease prevention begin? N Engl J Med 1998;338:1690-2. [9614263] [doi:10.1056/NEJM199806043382310]
2. Kojuri J, Karimi A, Pourafshar N, Vosoughi AR. Association between serum levels of Hs-CRP and LDL-C with degree of coronary artery stenosis in patients with stable angina pectoris. Iran Red Crescent Med J 2010;12:396-405.
3. Pajukanta P, Cargill M, Viitanen L, Nuotio I, Kareinen A, Perola M, Terwilliger JD, Kempas E, Daly M, Lilja H, Rioux JD, Brettin T, Viikari JS, Rönnemaa T, Laakso M, Lander ES, Peltonen L. Two loci on chromosomes 2 and X for premature coronary heart disease identified in early- and late-settlement populations of Finland. Am J Hum Genet 2000;67:1481-93. [11078477] [doi:10.1086/316902]
4. Kim YS, Zhuang H, Koehler RC, Doré S. Distinct protective mechanisms of HO-1 and HO-2 against hydroperoxide-induced cytotoxicity. Free Radic Biol Med 2005;38:85-92. [15589375] [doi:10.1016/j.freerad-biomed.2004.09.031]
5. Maines MD. The heme oxygenase system: a regulator of second messenger gases. Annu Rev Pharmacol Toxicol 1997;37:517-54. [9131263] [doi:10.1146/annurev.pharmtox.37.1.517]
6. Siow RC, Sato H, Mann GE. Heme oxygenase-carbon monoxide signal-ling pathway in atherosclerosis: anti- atherogenic actions of bilirubin and carbon monoxide? Cardiovasc Res 1999;41:385-94. [10341838] [doi:10.1016/S0008-6363(98)00278-8]
7. Namiki M, Kawashima S, Yamashita T, Ozaki M, Hirase T, Ishida T, Inoue N, Hirata K, Matsukawa A, Morishita R, Kaneda Y, Yokoyama M. Local overexpression of mono cyte chemoattractant protein-1 at vessel wall induces infiltration of macrophages and formation of atherosclerotic lesion: synergism with hypercholesterolemia. Arterio-scler Thromb Vasc Biol 2002; 22:115-20. [11788470] [doi:10.11 61/hq0102.102278]
8. Zakhary R, Gaine SP, Dinerman JL, Ruat M, Flavahan NA, Snyder SH. Heme oxygenase 2: endothelial and neuronal localization and role in endothelium-dependent relaxation. Proc Natl Acad Sci U S A 1996; 93:795-8. [8570637] [doi:10.1073/pnas.93.2.795]
9. Sambrook J, Frisch E. Molecular cloning: a laboratory manual. NY: Cold Spring Harbor, 1989.
10. Hayashi K. PCR-SSCP: a simple and sensitive method for detection of mutations in the genomic DNA. PCR Methods Appl 1991;1:34-8.[1842918]
11. Williams SE, Wootton P, Mason HS, Bould J, Iles DE, Riccardi D, Peers C, Kemp PJ. Hemoxygenase-2 is an oxygen sensor for a calcium-sensitive potassium channel. Science 2004;306:2093-7. [15528406] [doi:10.1126/science.1105010]